Harrison P J, Procter A W, Barton A J, Lowe S L, Najlerahim A, Bertolucci P H, Bowen D M, Pearson R C
Department of Anatomy and Cell Biology, St. Mary's Hospital Medical School, London, U.K.
Brain Res Mol Brain Res. 1991 Jan;9(1-2):161-4. doi: 10.1016/0169-328x(91)90143-l.
In situ hybridization histochemistry has been used to study the amount of M1 muscarinic receptor mRNA in temporal cortex from subjects with Alzheimer's disease and other neurodegenerative disorders, where the duration of terminal coma was known. Total polyadenylated mRNA and glutamate decarboxylase activity were also measured. Both muscarinic receptor mRNA and enzyme activity showed a significant decline with increasing duration of terminal coma, but were not related to diagnosis. Polyadenylated mRNA signal did not show an association with coma. These data indicate the need to consider the nature of the terminal illness in post mortem studies of mRNA as well as for neurochemical research.
原位杂交组织化学已被用于研究患有阿尔茨海默病和其他神经退行性疾病且已知终末期昏迷持续时间的受试者颞叶皮质中M1毒蕈碱受体mRNA的含量。还测量了总多聚腺苷酸化mRNA和谷氨酸脱羧酶活性。毒蕈碱受体mRNA和酶活性均随着终末期昏迷持续时间的增加而显著下降,但与诊断无关。多聚腺苷酸化mRNA信号与昏迷无关联。这些数据表明,在mRNA的尸检研究以及神经化学研究中,需要考虑终末期疾病的性质。